Document is current
Any future updates will be listed below
-
Authors
Pavord, Ian D. https://orcid.org/0000-0002-4288-5973
Brightling, Christopher E. https://orcid.org/0000-0002-9345-4903
Korn, Stephanie
Martin, Nicole L.
Ponnarambil, Sandhia S. https://orcid.org/0009-0008-8310-6041
Molfino, Nestor A.
Parnes, Jane R.
Ambrose, Christopher S. https://orcid.org/0000-0003-4175-7336
-
Funding
Funding for this research was provided by:
Amgen
AstraZeneca
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 18 March 2025
First Online: 26 April 2025
Declarations
:
: Ian D. Pavord has received speaker fees from Aerocrine AB, Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Novartis, Regeneron Pharmaceuticals, Sanofi and Teva Pharmaceuticals; has received payments for organization of educational events from AstraZeneca, GSK, Regeneron Pharmaceuticals, Sanofi and Teva Pharmaceuticals; has received consultancy fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, Dey Pharma, Genentech, GSK, Knopp Biosciences, Merck, MSD, Napp Pharmaceuticals, Novartis, Regeneron Pharmaceuticals, RespiVert, Sanofi, Schering-Plough and Teva Pharmaceuticals; has received international scientific meeting sponsorship from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Napp Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi and Teva Pharmaceuticals; and has received a research grant from Chiesi. Christopher E. Brightling has received grants and consultancy fees from 4D Pharma, Areteia Therapeutics, AstraZeneca, Chiesi, Genentech, GSK, Global Access Diagnostics (formerly Mologic), Novartis, Regeneron Pharmaceuticals, Roche and Sanofi. Stephanie Korn has received fees for lectures and/or advisory board meetings from AstraZeneca, GSK, Novartis, Roche, Sanofi and Teva Pharmaceuticals. Nicole L. Martin, Sandhia S. Ponnarambil and Christopher S. Ambrose are employees of AstraZeneca and may own stock or stock options in AstraZeneca. Nestor A. Molfino and Jane R. Parnes are employees of Amgen and own stock in Amgen.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The original studies were conducted in accordance with the ethical principles of the Declaration of Helsinki, International Council for Harmonisation good clinical practice guidelines, and applicable regulatory requirements and consent was obtained from all study participants.
